PINK Simplify Health Care ETF
The Simplify Health Care ETF (PINK) seeks long term capital appreciation by providing investors with multi-cap exposure to groundbreaking and innovative companies in biotech, medtech, gene therapy, and other fast growing health care related sectors.
Michael Taylor serves as lead portfolio manager of the ETF and brings over two decades of experience managing long/short health care equity portfolios at leading hedge funds. PINK is the first 100% pro bono ETF focused on the health care sector and net profits will be donated for the benefit of the Susan G. Komen foundation on an annual basis.
PINK: Shares for the Cure Find out more.
Donations
$350,000
as of 09/01/25
Fund Overview
As of 06/12/2026
Distribution Rate Close
Distribution rate calculation employs the most recent distribution, and multiplies the payment by 12 (monthly) or 4 (quarterly) to get an annualized total. The annualized total is then divided by the most recent net asset value (NAV) to determine the distribution rate.The Distribution Rate is the annual rate an investor would receive if the most recently declared distribution, which includes option income, remained the same going forward. The Distribution Rate is calculated by multiplying an ETF’s Distribution per Share by twelve (12), and dividing the resulting amount by the ETF’s most recent NAV. The Distribution Rate represents a single distribution from the ETF and does not represent its total return. The distribution may include a combination of ordinary dividends, capital gains, and return of investor capital and has the potential to change during any given tax year. Please refer to the 19a-1 Notice, which can be found on the Fund’s website, for information regarding the composition of distributions, including return of capital. The final determination of a distribution’s tax character will be made on Form 1099-DIV.
Management Fees
This table describes the fees and expenses that you may pay if you buy, sell, and hold shares of the Fund. Investors purchasing or selling shares of the Fund in the secondary market may be subject to costs (including customary brokerage commissions) charged by their broker. The fee table located in the prospectus and updates in prospectus supplements prevail.
| Annual Fund Operating Expenses (expenses that you pay each year as a percentage of the value of your investment) | |
|---|---|
| Management Fees | 0.50% |
| Distribution and Service (12b-1) Fees | 0.00% |
| Other Expenses | 0.00% |
| Acquired Fund Fees and Expenses1 | 0.01% |
| Total Annual Fund Operating Expenses | 0.51% |
1. Acquired Fund Fees and Expenses are the indirect costs of investing in other investment companies. The operating expenses in this fee table do not correlate to the expense ratio in the Fund’s financial highlights because the financial statements include only the direct operating expenses incurred by the Fund.
Fund Performance (Total Return)
As of 05/31/2026 03/31/2026
| Cumulative | 1 Month | 3 Month | 6 Month | YTD | 1 Year | 3 Year | 5 Year | Since Inception |
|---|---|---|---|---|---|---|---|---|
| NAV | 8.28% | 4.06% | 0.22% | 3.39% | 34.24% | 54.24% | — | 55.05% |
| Market Price | 9.20% | 4.83% | 1.06% | 4.23% | 35.56% | 55.83% | — | 57.02% |
| Annualized | 1 Year | 3 Year | 5 Year | Since Inception |
|---|---|---|---|---|
| NAV | 34.24% | 15.54% | — | 9.90% |
| Market Price | 35.56% | 15.94% | — | 10.20% |
| Cumulative | 1 Year | 3 Year | 5 Year | Since Inception |
|---|---|---|---|---|
| NAV | 15.30% | 36.50% | — | 37.97% |
| Market Price | 15.71% | 37.00% | — | 38.76% |
| Annualized | 1 Year | 3 Year | 5 Year | Since Inception |
|---|---|---|---|---|
| NAV | 15.30% | 10.93% | — | 7.45% |
| Market Price | 15.71% | 11.06% | — | 7.59% |
| Calendar Year | NAV | Market Price |
|---|---|---|
| 2025 | 24.07% | 24.35% |
| 2024 | 8.87% | 8.81% |
| 2023 | 3.75% | 3.84% |
| 2022 | -4.27% | -4.44% |
| 2021 | — | — |
The performance data quoted represents past performance and is no guarantee of future results. Current performance may be lower or higher than the performance data quoted. Investment returns and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance data for the most recent month-end is available above.
NAV: The dollar value of a single share, based on the value of the underlying assets of the fund minus its liabilities, divided by the number of shares outstanding. Calculated at the end of each business day.
Market Price: The current price at which shares are bought and sold. Market returns are based upon the last trade price.
Growth of $10,000
The Growth of $10,000 chart reflects a hypothetical investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted. Results are not indicative of future performance.
The above frequency distribution chart presents information about the difference between the daily market price for shares of the Fund and the Fund's reported Net Asset Value. The amount that the Fund's market price is above the reported NAV is called the premium. The amount that the Fund's market price is below the reported NAV is called the discount. The market price is determined using the midpoint between the highest bid and the lowest offer on the listing exchange, as of the time that the Fund's NAV is calculated (usually 4:00 p.m. EST). The horizontal axis of the chart shows the premium or discount expressed in basis points. The vertical axis indicates the number of trading days in the period covered by the chart. Each bar in the chart shows the number of trading days in which the Fund traded within the premium/discount range indicated.
Portfolio Holdings
| Ticker | Name | Quantity | Weight |
|---|---|---|---|
| ABBV | ABBVIE INC USD 0.01 | 58,653 | 4.33% |
| ABT | ABBOTT LABS NPV | 18,698 | 0.53% |
| ABVX | ABIVAX SA EUR 0.01 ADR | 220 | 0.01% |
| AGL | AGILON HEALTH INC USD 0.01 | 7,670 | 0.28% |
| ALGN | ALIGN TECHNOLOGY INC USD 0.0001 | 60,841 | 3.45% |
| AMGN | AMGEN INC USD 0.0001 | 19,093 | 2.20% |
| AZN | ASTRAZENECA PLC USD 0.25 | 31,119 | 1.80% |
| BHVN | BIOHAVEN LTD NPV | 946,469 | 3.46% |
| BMY | BRISTOL MYERS SQUIBB CO USD 0.1 | 1,001 | 0.02% |
| BNTC | BENITEC BIOPHARMA INC NPV | 837,076 | 3.03% |
| BSX | BOSTON SCI COM USD0.01 | 13,661 | 0.21% |
| CAH | CARDINAL HEALTH INC NPV | 24,515 | 1.78% |
| COO | COOPER COS INC USD 0.1 | 11,994 | 0.26% |
| CVS | CVS HEALTH CORPORATION USD 0.01 | 63,286 | 2.09% |
| CYPH | CYPHERPUNK TECHNOLOGIES INC. COMMON | 25,471 | 0.01% |
| DHR | DANAHER CORP USD 0.01 | 38,973 | 2.28% |
| ELV | ELEVANCE HEALTH INC USD 0.01 | 23,018 | 3.01% |
| EMBC | EMBECTA CORP USD 0.01 | 2,666 | 0.00% |
| ESTA | ESTABLISHMENT LABS HOLDINGS USD 1.0 | 55,095 | 1.47% |
| EW | EDWARDS LI COM USD1 | 16,985 | 0.47% |
| EYPT | EYEPOINT INC | 328,875 | 1.39% |
| FLR | FLUOR CORP NEW USD 0.01 | 5,672 | 0.09% |
| FULC | FULCRUM THERAPEUTICS INC USD 0.001 | 139,934 | 0.16% |
| GEHC | GE HEALTHCARE TECHNOLOGIES USD 0.01 | 47,354 | 1.00% |
| GH | GUARDANT HEALTH INC USD 0.00001 | 25,096 | 1.07% |
| GILD | GILEAD SCIENCES INC USD 0.001 | 73,999 | 2.99% |
| HQY | HEALTHEQUITY INC USD 0.0001 | 371 | 0.01% |
| ICLR | ICON PLC EUR 0.06 | 1,367 | 0.06% |
| INSM | INSMED INC USD 0.01 | 12,326 | 0.39% |
| ISRG | INTUITIVE SURGICAL INC USD 0.001 | 6,832 | 0.91% |
| JAZZ | JAZZ PHARMACEUTICALS PLC USD 0.0001 | 62,389 | 4.66% |
| JNJ | JOHNSON + JOHNSON USD 1.0 | 70,027 | 5.47% |
| LLY | LILLY ELI + CO NPV | 16,094 | 5.91% |
| NBIX | NEUROCRINE BIOSCIENCES IN USD 0.001 | 3,018 | 0.16% |
| NVO | NOVO-NORDISK A S DKK 10.0 ADR | 459,411 | 6.53% |
| PCRX | PACIRA BIOSCIENCES INC USD 0.001 | 75,592 | 0.56% |
| PCT | PURECYCLE TECHNOLOGIES I USD 0.0001 | 2,773,366 | 7.98% |
| PRAX | PRAXIS PRECISION MEDICIN USD 0.0001 | 339 | 0.03% |
| REGN | REGENERON PHARMACEUTICALS USD 0.001 | 78 | 0.02% |
| SNDX | SYNDAX PHARMACEUTICALS I USD 0.0001 | 742 | 0.00% |
| SRPT | SAREPTA THERAPEUTICS INC USD 0.0001 | 7,000 | 0.03% |
| SYK | STRYKER CORP USD 0.1 | 2,052 | 0.21% |
| TFX | TELEFLEX INC USD 1.0 | 1,337 | 0.06% |
| TGTX | TG THERAPEUTICS INC USD 0.001 | 19,355 | 0.31% |
| TMO | THERMO FISHER SCIENTIFIC IN USD 1.0 | 21,000 | 3.19% |
| TXG | 10X GENOMICS INC USD 0.00001 | 266,538 | 2.49% |
| UNH | UNITEDHEALTH GROUP INC USD 0.01 | 45,240 | 5.96% |
| UTHR | UNITED THERAPEUTICS CORP D USD 0.01 | 41,319 | 7.31% |
| VLTO | VERALTO CORP USD 0.01 | 702 | 0.02% |
| VRTX | VERTEX PHARMACEUTICALS INC USD 0.01 | 9,532 | 1.37% |
| WRBY | WARBY PARKER INC USD 0.0001 | 587,415 | 5.04% |
| ZBH | ZIMMER BIOMET HLDGS INC USD 0.01 | 3,999 | 0.11% |
| - | Estimated Cash | 11,704,976 | 3.79% |
Holdings are subject to change without notice.
Recent Distributions
| Ex-Dividend Date | Record Date | Payable Date | Total Distribution |
|---|---|---|---|
| N/A | |||
| $0.05000 | |||
| $0.10000 | |||
| $0.05000 | |||
| $0.05000 |